SEI Investments’s Aclaris Therapeutics ACRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-25,189
| Closed | -$38.5K | – | 2785 |
|
|
2025
Q1 | $38.5K | Buy |
+25,189
| New | +$38.5K | ﹤0.01% | 2696 |
|
|
2019
Q2 | – | Sell |
-3,277
| Closed | -$18K | – | 2378 |
|
|
2019
Q1 | $18K | Sell |
3,277
-10,710
| -77% | -$58.8K | ﹤0.01% | 2752 |
|
|
2018
Q4 | $103K | Buy |
13,987
+13,951
| +38,753% | +$103K | ﹤0.01% | 2191 |
|
|
2018
Q3 | $0 | Buy |
36
+35
| +3,500% | – | ﹤0.01% | 2506 |
|
|
2018
Q2 | $0 | Sell |
1
-1,048
| -100% | – | ﹤0.01% | 3596 |
|
|
2018
Q1 | $18K | Buy |
1,049
+169
| +19% | +$2.9K | ﹤0.01% | 2675 |
|
|
2017
Q4 | $22K | Sell |
880
-7,391
| -89% | -$185K | ﹤0.01% | 2573 |
|
|
2017
Q3 | $214K | Sell |
8,271
-2,769
| -25% | -$71.6K | ﹤0.01% | 1853 |
|
|
2017
Q2 | $300K | Buy |
11,040
+10,663
| +2,828% | +$290K | ﹤0.01% | 1771 |
|
|
2017
Q1 | $11K | Sell |
377
-2,223
| -86% | -$64.9K | ﹤0.01% | 2441 |
|
|
2016
Q4 | $71K | Buy |
+2,600
| New | +$71K | ﹤0.01% | 2043 |
|